Capital Research Global Investors
BHVN icon

Capital Research Global Investors’s Biohaven BHVN Stock Holding History

Capital Research Global Investors’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$17.8M Sell
1,199,545
-133,247
-10% -$1.43M ﹤0.01% 397
2026
Q1 		$11.3M Hold
1,332,792
– – ﹤0.01% 425
2025
Q4 		$15M Buy
1,332,792
+321,262
+32% +$3.98M ﹤0.01% 404
2025
Q3 		$15.2M Buy
1,011,530
+527,337
+109% +$7.68M ﹤0.01% 407
2025
Q2 		$6.83M Buy
+484,193
New +$8.63M ﹤0.01% 407

Other funds holding BHVN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AIP
ARS Investment Partners New York $2.29B AUM 113.95% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Capital Research Global Investors's BHVN Position: Q2 2026 in Review

Capital Research Global Investors reduced its Biohaven (BHVN) stake by 10% in Q2 2026, selling an estimated $1.43M and leaving 1,199,545 shares worth $17.8M. The position accounts for ﹤0.01% of the portfolio, ranked #397.

Capital Research Global Investors first reported a position in BHVN in Q2 2025 and has held it in 5 quarters since. 188 funds tracked by Wall St. Rank hold BHVN as of Q2 2026.

  • Capital Research Global Investors held 1,199,545 shares of Biohaven worth $17.8M as of Q2 2026.
  • Capital Research Global Investors sold 133,247 Biohaven shares in Q2 2026, an estimated $1.43M.
  • Biohaven made up ﹤0.01% of Capital Research Global Investors's portfolio in Q2 2026, its #397 holding.
  • Capital Research Global Investors first reported a position in Biohaven in Q2 2025 and has held it in 5 quarters since.
  • 188 funds tracked by Wall St. Rank held Biohaven as of Q2 2026.

Based on Capital Research Global Investors's 13F filing for Q2 2026, filed 12 Aug 2026.